208 research outputs found
Referral Patterns in Oral Medicine: A Retrospective Analysis of an Oral Medicine University Center in Southern Italy
Referral of a patient from one healthcare provider to another is an important part of the medical practice. The aim of this study was to analyze the referral process to the Oral Medicine Unit in a university-based tertiary center in Southern Italy. A chart review of new referrals to the Oral Medicine Unit during a 24-month period was conducted. The following data were recorded: demographic characteristics, medical history, number of physicians seen prior to Oral Medicine assessment, referral source, diagnostic procedures ordered by referrals, reason for referral, site of lesion/condition, final diagnosis. Then, the rates of correct identification for health-care professionals and the appropriateness of the reference diagnosis based on the disease were calculated with descriptive statistic indicators. There were 583 new first consultations. A total of 62.9% of patients were referred by general dental practitioners, 27.4% by physicians, and 9.7% did not have a referral. The most common diseases for referral were immune-mediated diseases (39.6%) and oro-facial pain disorders (25.2%). Only 28.5% of patients had a correct provisional diagnosis. The results of this study show the need to implement curricula in the field of oral medicine among dentistry and medical students, and to support the continuing education among healthcare providers to reduce diagnostic delay for oral diseases
Sleep Disturbance in Patients with Burning Mouth Syndrome: A Case-Control Study
AIM:
To examine sleep complaints in patients with burning mouth syndrome (BMS) and the relationships between these disturbances, negative mood, and pain.
METHODS:
Fifty BMS patients were compared with an equal number of healthy controls matched for age, sex, and educational level. The Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), the Hamilton Rating Scales for Depression (HAM-D) and Anxiety (HAM-A) were administered. Descriptive statistics, including the Mann-Whitney U test and hierarchical multiple linear regression analyses were used.
RESULTS:
BMS patients had higher scores in all items of the PSQI and ESS than the healthy controls (P < .001). In the BMS patients, a depressed mood and anxiety correlated positively with sleep disturbances. The Pearson correlations were 0.68 for PSQI vs HAM-D (P < .001) and 0.63 for PSQI vs HAM-A (P < .001).
CONCLUSION:
BMS patients reported a greater degree of sleep disorders, anxiety, and depression as compared with controls. Sleep disorders could influence quality of life of BMS patients and could be a possible treatment target
Immunocytometric analysis of oral pemphigus vulgaris patients after treatment with rituximab as adjuvant
Background: B-cell depletion therapy was demonstrated to be a valid and safe alternative as an adjuvant in oral-pharyngeal pemphigus vulgaris (OPV) patients. We aimed to assess its effects on anti-desmoglein (Dsg) 1 and 3 and leukocytes subsets profile in these patients’ population. Methods and Materials: We evaluated the immunologic profile of 10 OPV patients treated with RTX as adjuvant by using the ELISA testing for anti-Dsg-1 and -3 titers and the immunophenotyping for B and T-cell lymphocyte subpopulations and compared them with the PDAI score for clinical remission. Results: A significant difference in medians between baseline, end of RTX therapy, and 6 months after RTX therapy was observed in Dsg-3 titer (p 0.001), in the CD8 (p = 0.009), and CD20 counts (p 0.001). Multiple comparisons after Bonferroni adjustment confirmed such significant differences mainly between baseline and the end of RTX therapy and baseline and 6 months after RTX therapy. Only the anti-Dsg-3 titer at the end of RTX therapy demonstrated a slight positive correlation with the PDAI score at baseline (p = 0.046, r = 0.652). Conclusions: B-cell depletion adjuvant therapy in OPV patients demonstrated a significant impact on anti-Dsg-3 titer and B and T-cell lymphocyte subpopulations profile
Sleep Disorders and Psychological Profile in Oral Cancer Survivors: A Case-Control Clinical Study
Quality of sleep (QoS) and mood may impair oral cancer survivors’ wellbeing, however few evidences are currently available. Therefore, we aimed to assess the prevalence of sleep disorders, anxiety and depression among five-year oral cancer survivors (OC survivors). 50 OC survivors were compared with 50 healthy subjects matched for age and sex. The Pittsburgh Sleep Quality Index (PSQI), the Epworth Sleepiness Scale (ESS), the Hamilton Rating Scales for Depression and Anxiety (HAM-D, HAM-A), the Numeric Rating Scale (NRS), the Total Pain Rating Index (T-PRI) were administered. The global score of the PSQI, ESS, HAM-A, HAM-D, NRS, T-PRI, was statistically higher in the OC survivors than the controls (p-value: <0.001). QoS of OC survivors was significantly impaired, especially with regard to some PSQI sub-items as the subjective sleep quality, sleep latency and daytime dysfunction (p-value: 0.001, 0.029, 0.004). Moreover, poor QoS was negatively correlated with years of education (p-value: 0.042 *) and positively correlated with alcohol consumption (p-value: 0.049 *) and with the use of systemic medications (p-value: 0.044 *). Sleep disorders and mood disorders are common comorbidities in OC survivors; therefore, early assessment and management before, during and after treatment should be performed in order to improve the quality of life of OC survivors
Oral Mucosa and Nails in Genodermatoses: A Diagnostic Challenge
Genodermatoses represent a group of uncommon, hereditary, single-gene skin disorders,
characterized by multisystem involvement, heterogeneous clinical manifestations and different degrees
of morbidity and mortality. Some genodermatoses may have oral mucosa and nail involvement,
since the oral cavity and cutaneous organ system, including nails, share a close embryologic origin.
Nail disorders can manifest with nail hypoplasia or nail hypertrophy. Clinical pictures of affected
oral mucosa can be extremely heterogeneous, ranging from asymptomatic papules to painful blisters,
leukokeratosis, oral papillomas and fibromas to oral potentially malignant disorders and cancerous
lesions. Oral mucosa and nails pathological features may occur synchronously or not and are usually
associated with other systemic and skin manifestations. In some cases, oral mucosa and nails diseases
may be distinct and constitute the principal sign of the genetic disorder, in other cases they represent
only a part of the puzzle for the confirmation of the diagnosis. Continued awareness of the correlation
between oral mucosa and nails findings can help physicians to diagnose genodermatosis in a timely
manner, allowing more effective clinical management and prevention and/or early detection of
complications. This article provides an overview of all specific genodermatoses affecting both oral
mucosa and nails. Moreover, the correlation between teeth and nails is summarized in tabular form
Burning Fog: Cognitive Impairment in Burning Mouth Syndrome
Background: Due to its common association with chronic pain experience, cognitive impairment (CI) has never been evaluated in patients with burning mouth syndrome (BMS). The purpose of this study is to assess the prevalence of CI in patients with BMS and to evaluate its relationship with potential predictors such as pain, mood disorders, blood biomarkers, and white matter changes (WMCs).
Methods: A case-control study was conducted by enrolling 40 patients with BMS and an equal number of healthy controls matched for age, gender, and education. Neurocognitive assessment [Mini Mental State Examination (MMSE), Digit Cancellation Test (DCT), the Forward and Backward Digit Span task (FDS and BDS), Corsi Block-Tapping Test (CB-TT), Rey Auditory Verbal Learning Test (RAVLT), Copying Geometric Drawings (CGD), Frontal Assessment Battery (FAB), and Trail Making A and B (TMT-A and TMT-B)], psychological assessment [Hamilton Rating Scale for Depression and Anxiety (HAM-D and HAM-A), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and 36-Item Short Form Health Survey (SF-36)], and pain assessment [Visual Analogic Scale (VAS), Total Pain Rating index (T-PRI), Brief Pain Inventory (BPI), and Pain DETECT Questionnaire (PD-Q)] were performed. In addition, blood biomarkers and MRI of the brain were recorded for the detection of Age-Related WMCs (ARWMCs). Descriptive statistics, the Mann-Whitney U-test, the Pearson Chi-Squared test and Spearman's correlation analysis were used.
Results: Patients with BMS had impairments in most cognitive domains compared with controls (p < 0.001**) except in RAVLT and CGD. The HAM-D, HAM-A, PSQI, ESS, SF-36, VAS, T-PRI, BPI and PD-Q scores were statistically different between BMS patients and controls (p < 0.001**) the WMCs frequency and ARWMC scores in the right temporal (RT) and left temporal (LT) lobe were higher in patients with BMS (p = 0.023*).
Conclusions: Meanwhile, BMS is associated with a higher decline in cognitive functions, particularly attention, working memory, and executive functions, but other functions such as praxis-constructive skills and verbal memory are preserved. The early identification of CI and associated factors may help clinicians to identify patients at risk of developing time-based neurodegenerative disorders, such as Alzheimer's disease (AD) and vascular dementia (VD), for planning the early, comprehensive, and multidisciplinary assessment and treatment
HSP 27 aspossible prognostic factor in patients with oral squamous cell carcinoma.
Summary. HSP27 belongs to the Heat shock protein
(HSP) family, which plays essential functions in cells
under physiological conditions and prevents stressinduced
cellular damage. The aim of this study was to
investigate the biological role of HSP27 in oral
tumorigenesis. Materials and methods: Seventy-nine
cases of oral squamous cell carcinoma and 10 cases of
normal mucosa were analysed for HSP27 expression by
immunohistochemistry. Moreover, the western blot
analysis was performed on two cases of normal mucosa
and five cases of OSCC. Results: Normal oral mucosa
showed a suprabasal expression of HSP27. Twenty-four
cases of SCC (30.7%) showed a diffuse staining for
HSP27, and 48 cases (60.3%) showed instead a decrease
in staining, which was diffuse, homogeneous, or with
alternation of positive and negative areas in a single
tumor (“mosaic” pattern). Only 7 cases of OSCC (7.5%)
were completely negative for HSP27. Frequency of
lymph node metastases was higher in HSP27-negative
tumours (3/7, 42.8%) than in HSP-reduced (16/48,
33.3%) or positive ones (5/26, 19.2%). Regard staging,
stages I and II had a higher score than stages III and IV
(stage I > stage II > stage III > stage IV). There was also
a statistically significant correlation between HSP27
expression and grade: HSP27 expression was reduced in
poorly differentiated tumours (P < 0.05). When analysed
for prognostic significance, patients with
negative/reduced HSP27 expression had poorer survival
rates than the group with positive HSP27 expression (P
< 0.05). The statistical analysis of these findings showed
no significant correlation between HSP27 expression,
sex, and tumour size. Conclusion: Cases with reduced
expression were more aggressive and poorly
differentiated. These data suggest that HSP27 expression may be useful in order to identify cases of oral squamous
cell carcinoma with more aggressive and invasive
phenotype providing novel diagnostic and prognostic
information on individual patient survival with oral
cancers
Anxiety and depression in keratotic oral lichen planus: a multicentric study from the SIPMO
Objectives: Oral lichen planus with exclusive keratotic reticular, papular, and/or plaque-like lesions (K-OLP) is a clinical pattern of OLP that may be associated with a complex symptomatology and psychological alteration. The aim of the study was to evaluate the prevalence of anxiety (A) and depression (D) in patients with K-OLP, analyzing the potential predictors which can affect mental health status. Methods: Three hundred K-OLP patients versus 300 healthy controls (HC) were recruited in 15 Italian universities. The Numeric Rating Scale (NRS), Total Pain Rating Index (T-PRI), and Hamilton Rating Scales for Depression and for Anxiety (HAM-D and HAM-A) were administered. Results: The K-OLP patients showed statistically higher scores in the NRS, T-PRI, HAM-D, and HAM-A compared with the HC (p-value < 0.001**). A and D were found in 158 (52.7%) and 148 (49.3%) K-OLP patients. Strong linear correlations were identified between HAM-A, HAM-D, NRS, T-PRI, and employment status and between HAM-D, HAM-A, NRS, T-PRI, employment status, and female gender. Multivariate logistic regression revealed that HAM-D and HAM-A showed the greatest increase in the R2 value for A and D in the K-OLP patients, respectively (DR2 = 55.5% p-value < 0.001**; DR2 = 56.5% p-value < 0.001**). Conclusions: The prevalence of A and D is higher in the K-OLP patients compared with the HC, also found in K-OLP subjects without pain, suggesting that the processing of pain may be in a certain way independent of the processing of mood. Clinical relevance: Mood disorders and pain assessment should be carefully performed in relation to K-OLP to obtain a complete analysis of the patients
- …